arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Meihua International Medical Technologies Co., Ltd.

MHUAF

— Price unavailable

8 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Meihua International Medical Technologies Co., Ltd. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth -36.2% ↘

Op. Margin 13.4% ↘

ROIC 3.2% ↘

FCF / Share $1.47 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity 0.05

info Valuation on last close.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$61.79M

↓ -36.2% —

Net Income Profit after all expenses

$6.78M

↓ -37.5% —

Operating Margin Operating profit as % of sales

13.4%

↓ -9.2% 64th

FCF / Share Free cash flow per share

$1.47

↑ +178.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Revenue Growth YoY (%)	-36.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-553%)	-0.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-102%)	-6.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-176%)	-0.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-108%)	16.8% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+110%)	11.8% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+48%)	—	—
EPS Growth YoY (%)	4410.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-18.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	81.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-74.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.5% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	14.5% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-37.5% Weak ↓ Weak Declining Year-over-year change in net income	-6.7% Weak ↓ Weak Declining Year-over-year change in net income	86.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-70.2% Weak ↓ Weak Declining Year-over-year change in net income	10.0% Fair Fair Year-over-year change in net income	23.4% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	178.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	1060.5% Excellent Excellent Year-over-year change in free cash flow	N/M	-1019.9% Weak Weak Year-over-year change in free cash flow	N/M	-84.4% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-15.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-2.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	2.9% Caution Caution Compound annual revenue growth over 3 years	9.1% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-7.1% Weak Weak Compound annual revenue growth over 5 years	4.0% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	305.8% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	-27.5% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-19.8% Weak Weak Compound annual EPS growth over 3 years	-31.2% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Operating Margin (%) (%)	13.4% Fair → Fair Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-11%)	14.8% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	15.1% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	10.5% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-30%)	25.2% Excellent → Excellent Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+68%)	26.3% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+76%)	24.3% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+62%)	—
Effective Tax Rate (%) (%)	27.9% Caution → Caution Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.5% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	23.0% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	43.3% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.1% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.8% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.8% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	11.0% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	11.2% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-7%)	12.0% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	6.0% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-50%)	20.1% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+68%)	21.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+78%)	19.4% Good Good Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+61%)	—
FCF Margin (%) (%)	0.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	15.0% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	1.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-11.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-0.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	1.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	11.4% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.08x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.34x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.90x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Return on Invested Capital (%)	3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	7.7% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	4.4% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	19.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	22.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	26.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	4.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	7.7% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	8.5% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	6.6% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	19.2% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	22.1% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-76%)	6.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	7.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-47%)	4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-70%)	19.4% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+30%)	22.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+50%)	25.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+72%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Debt to Equity (x)	0.05x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.04x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	—	—
Interest Coverage (x)	34.30x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	57.80x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	58.52x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	56.50x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	145.29x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	171.09x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	198.26x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$8.99M	$7.95M	$7.32M	$-20.65M	$-2.97M	$-3.97M	—	—
Debt / EBITDA (x)	1.02x Good ↑ Good Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.53x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.49x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.54x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.19x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Revenue per Share (USD)	$164.33	$3.54	$4.06	$4.41	$5.20	$4.45	$4.29	—
Basic EPS, GAAP (USD)	$18.04	$0.40	$0.49	$0.27	$1.05	$0.95	$0.83	—
Free Cash Flow per Share (USD)	$1.47	$0.53	$0.05	$-0.51	$-0.05	$0.08	$0.49	—
Book Value per Share (USD)	$502.43	$4.98	$6.11	$5.77	$5.39	$4.24	$3.21	—
Tangible Book Value per Share (USD)	$501.24	$4.72	$5.95	$5.75	$5.36	$4.21	$3.21	—
Basic Weighted Avg Shares (shares)	376,035	27.37M	23.94M	23.41M	20.00M	20.00M	18.57M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Working Capital (USD)	$135.33M	$116.17M	$107.16M	$111.15M	$68.19M	$46.25M	—	—
Total Equity (USD)	$188.93M	$158.98M	$146.33M	$138.12M	$107.77M	$84.74M	$59.66M	$44.46M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Sales/Revenue/Turnover (USD)	$61.79M	$96.91M	$97.10M	$103.35M	$104.04M	$89.06M	$79.63M	—
Depreciation Expense (USD)	$533.96K	$543.66K	$408.23K	$541.26K	$595.52K	$497.24K	$481.06K	—
Net Income, GAAP (USD)	$6.78M	$10.84M	$11.63M	$6.24M	$20.95M	$19.05M	$15.43M	—
Operating Cash Flow (USD)	$569.88K	$14.64M	$2.28M	$-9.16M	$-54.66K	$5.33M	$9.31M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 8 quarters

Meihua International Medical Technologies Co., Ltd.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MHUAF with peers